The Parkinson’s disease treatment market value across the eight major countries of the US, France, Germany, Italy, Spain, the UK, Japan, and Brazil will reach $4.7 billion by 2022, driven primarily by an aging population and increasing disease prevalence.

Reportstack’s latest report "PharmaPoint: Parkinsons Disease-Global Drug Forecast...